Sherpa Clinical Packaging has completed a new 37,500 ft2 clinical packaging and distribution facility in San Diego, US.
Featuring cold chain management infrastructure, the new facility provides purpose built space for primary and secondary clinical labeling and packaging.
The facility also offers GMP storage for refrigerated (2-8oC), frozen (-20oC, -80oC and LN2), and controlled room temperature (20-25oC), and temperature controlled shipping dispatch.
In addition, the facility features an ISO 8 clean room for primary packaging of solid dose products.
With the new centre, the firm is also providing cold form and thermoform blistering, blister strip carding, pouching and API storage services.
According to the company, the expansion will support its increased demand for Phase II and Phase III clinical studies.
Sherpa Clinical Packaging president Mark Paiz said: "We are excited to be able to provide the diversity and quality of services to a large number of clients in all phases of clinical trials.
"Sherpa's mission is to be the customer service leader in the clinical trial materials management business and we offer each client the trusting and reliable relationship that people vested in clinical trials seek."
Sherpa provides clinical trial material management services for clinical studies ranging from phases I to IV.
The services comprise of packaging, labeling, distribution and returns/reconciliation for pharmaceutical, biotechnology, medical device and dietary supplement companies.
